Close mobile menu×
Close mobile menu

Karen S. Marder, MD, MPH

Board Certifications: 
Neurology
Accepting New Patients
Profile Headshot

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Neurology

Clinical Expertise

  • Alzheimer's Disease
  • Behavioral Disorder
  • Dementia
  • Huntington Disease
  • Memory Loss

Specialties

Education & Training

  • Cornell University Medical College, NY
  • Internship: St. Luke's-Roosevelt Hospital Center
  • Residency: Columbia University Medical Center
  • Fellowship: Columbia University Medical Center

About Karen Marder

Karen Marder, MD, MPH is the Sally Kerlin Professor of Neurology at Columbia University Medical Center. She has served as the Chief of the Division of Aging and Dementia since 2001 and has directed the United Council for Neurologic Subspecialties (UCNS) fellowship in Behavioral Neurology and Neuropsychiatry since its inception.

In both research and patient care, Dr. Marder is focused on the epidemiology and treatment of cognitive, behavioral, and motor impairments in a range of neurodegenerative diseases, including Parkinson’s disease (PD), Huntington’s Disease (HD), HIV dementia, Alzheimer’s disease (AD) and related disorders.

Since 1998, Dr. Marder has been characterizing the earliest motor and non-motor signs associated with genetic forms of PD. She served as co-chair and chair of the Executive Committee of the Parkinson Study Group (2006-2012), a consortium of North American investigators participating in collaborative PD research at 120 sites. She is the founding (1991) and current director of the multidisciplinary Huntington's Disease Society of America Center of Excellence at Columbia, and also serves as associate director of the Irving Institute for Clinical and Translational Research (CTSA). In addition, Dr. Marder is co-prinicipal investigator of the Columbia University–Weill Cornell NIH-funded NeuroNEXT site, a clinical trial network whose goal is to conduct Phase II biomarker informed neurological clinical trials over a 7-year period.

Academic Titles

  • Sally Kerlin Professor of Neurology (in the Gertrude H. Sergievsky Center, in the Taub Institute on Alzheimer's Disease and the Aging Brain, and in Psychiatry) at CUMC

Administrative Positions

  • Chief, Division of Aging and Dementia
  • Associate Director, Irving Institute for Clinical and Translational Research
  • Director, Clinical Research Resource, Irving Institute
  • Director, Huntington's Disease Center

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
710 West 168th Street
New York, New York 10032
Primary

Research

Dr. Marder's research has focused on the epidemiology and treatment of cognitive, behavioral, and motor impairments in a range of neurodegenerative diseases, including Parkinson’s disease (PD), Huntington’s Disease (HD), HIV dementia, and Alzheimer’s disease (AD) and related disorders. Most recently, my focus has been on characterizing the earliest signs associated with genetic forms of PD including Parkin, LRRK2, and GBA mutations, especially in individuals with early-onset PD.

In May 2006, I was elected to a 6-year term as co-chair of the Executive Committee of the Parkinson Study Group, a consortium of North American investigators participating in collaborative PD research at 120 sites.

I established the Huntington's Disease Society of America Center of Excellence at Columbia University in 1991, which I continue to lead today. We conduct a wide range of observational research and clinical trials for people with HD and those at risk.

I am particularly interested in the knowledge and attitudes of people at risk for genetic disorders. At Columbia, I also serve as associate director of the Irving Institute for Clinical and Translational Research (CTSA) where I direct the Clinical Research Resource for adult and pediatric inpatient and outpatient research. I am also the co-Principal Investigator for the Columbia/Weill-Cornell site of the NINDS-funded NeuroNEXT clinical trial network, whose mission is to conduct Phase 2 biomarker informed studies of neurological diseases.

Research Interests

  • Neuropsychiatry/Cognitive Disorders